Literature DB >> 21586364

P2X receptors in health and disease.

G Burnstock1, C Kennedy.   

Abstract

Seven P2X receptor subunits have been cloned which form functional homo- and heterotrimers. These are cation-selective channels, equally permeable to Na(+) and K(+) and with significant Ca(2+) permeability. The three-dimensional structure of the P2X receptor is described. The channel pore is formed by the α-helical transmembrane spanning region 2 of each subunit. When ATP binds to a P2X receptor, the pore opens within milliseconds, allowing the cations to flow. P2X receptors are expressed on both central and peripheral neurons, where they are involved in neuromuscular and synaptic neurotransmission and neuromodulation. They are also expressed in most types of nonneuronal cells and mediate a wide range of actions, such as contraction of smooth muscle, secretion, and immunomodulation. Changes in the expression of P2X receptors have been characterized in many pathological conditions of the cardiovascular, gastrointestinal, respiratory, and urinogenital systems and in the brain and special senses. The therapeutic potential of P2X receptor agonists and antagonists is currently being investigated in a range of disorders, including chronic neuropathic and inflammatory pain, depression, cystic fibrosis, dry eye, irritable bowel syndrome, interstitial cystitis, dysfunctional urinary bladder, and cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586364     DOI: 10.1016/B978-0-12-385526-8.00011-4

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  72 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells.

Authors:  Lori L Stohl; Julie B Zang; Wanhong Ding; Michela Manni; Xi K Zhou; Richard D Granstein
Journal:  Cytokine       Date:  2013-09-08       Impact factor: 3.861

3.  Molecular mechanism of ATP binding and ion channel activation in P2X receptors.

Authors:  Motoyuki Hattori; Eric Gouaux
Journal:  Nature       Date:  2012-05-10       Impact factor: 49.962

4.  Quantifying Ca2+ current and permeability in ATP-gated P2X7 receptors.

Authors:  Xin Liang; Damien S K Samways; Kyle Wolf; Elizabeth A Bowles; Jennifer P Richards; Jonathan Bruno; Sébastien Dutertre; Richard J DiPaolo; Terrance M Egan
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

5.  High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.

Authors:  Mariana Marin; Yuhong Du; Charline Giroud; Jeong Hwa Kim; Min Qui; Haian Fu; Gregory B Melikyan
Journal:  Assay Drug Dev Technol       Date:  2015-04-14       Impact factor: 1.738

6.  The Dynamic Behavior of the P2X4 Ion Channel in the Closed Conformation.

Authors:  Gustavo Pierdominici-Sottile; Luciano Moffatt; Juliana Palma
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

Review 7.  P2X4 receptors, immunity, and sepsis.

Authors:  Luca Antonioli; Corrado Blandizzi; Matteo Fornai; Pál Pacher; H Thomas Lee; György Haskó
Journal:  Curr Opin Pharmacol       Date:  2019-03-25       Impact factor: 5.547

Review 8.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.

Authors:  Diego Dal Ben; Anna Marchenkova; Ajiroghene Thomas; Catia Lambertucci; Andrea Spinaci; Gabriella Marucci; Andrea Nistri; Rosaria Volpini
Journal:  Purinergic Signal       Date:  2016-10-18       Impact factor: 3.765

10.  P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis.

Authors:  Weifeng Luo; Daniel Feldman; Reid McCallister; Colleen Brophy; Joyce Cheung-Flynn
Journal:  Purinergic Signal       Date:  2017-09-13       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.